Lung Therapeutics
is a Texas-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of lung diseases... Read moreLung Therapeutics
is a Texas-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of lung diseases... Read more
News
Oct 31, 2023
FinSMEs
Lung Therapeutics: Aileron Therapeutics Acquires Lung Therapeutics
Mar 23, 2022
Clinical Trials Arena
Lung Therapeutics: Lung Therapeutics concludes Phase Ia trial of IPF asset
Mar 14, 2022
SEC
Lung Therapeutics: Lung Therapeutics has Received $10.1M in Equity Funding
Nov 13, 2020
The Pharma Letter
Lung Therapeutics: Lung Tx sells Japanese rights to orphan drug candidate
Nov 12, 2020
MarketScreener
Lung Therapeutics: Taiho and Lung Therapeutics Enter Into an Exclusive License Agreement in Japan for LTI-01, Treatment for Loculated Pleural Effusions
Aug 21, 2020
Business Wire
Press Release: Lung Therapeutics : Lung Therapeutics Receives SBIR Award for Kidney Fibrosis Research; Principal Investigator BreAnne Mackenzie Will Speak at 4th Annual IPF Summit 2020/Digital
Aug 21, 2020
MarketScreener
Lung Therapeutics: Lung Therapeutics Receives SBIR Award for Kidney Fibrosis Research; Principal Investigator BreAnne Mackenzie Will Speak at 4th Annual IPF Summit 2020/Digital
Aug 11, 2020
Statesman
Lung Therapeutics: Austin's TFF Pharmaceuticals raises $25.9M with stock offering
Jun 05, 2019
The Business Journals
Lung Therapeutics: Lung Therapeutics releases details about $36M funding
Jun 04, 2019
FinSMEs
Lung Therapeutics: Lung Therapeutics Raises $36M in Series C Financing
Lung Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10